Norges Bank’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $869K | Sell |
|
|||||
|
2023
Q3 | $2.06M | Sell |
|
|||||
|
2023
Q2 | $3.82M | Hold |
|
|||||
|
2023
Q1 | $3.8M | Sell |
|
|||||
|
2022
Q4 | $5.56M | Sell |
|
|||||
|
2022
Q3 | $9.97M | Hold |
|
|||||
|
2022
Q2 | $10.5M | Sell |
|
|||||
|
2022
Q1 | $18.9M | Buy |
|
|||||
|
2021
Q4 | $24.3M | Buy |
|
|||||
|
2021
Q3 | $30.2M | Sell |
|
|||||
|
2021
Q2 | $41M | Buy |
|
|||||
|
2021
Q1 | $33.9M | Sell |
|
|||||
|
2020
Q4 | $28.7M | Sell |
|
|||||
|
2020
Q3 | $46.4M | Sell |
|
|||||
|
2020
Q2 | $60M | Buy |
|
|||||
|
2020
Q1 | $20.3M | Sell |
|
|||||
|
2019
Q4 | $27.7M | Buy |
|
|||||
|
2019
Q3 | $27.7M | Buy |
|
|||||
|
2019
Q2 | $19.9M | Buy |
|
|||||
|
2019
Q1 | $11.6M | Hold |
|
|||||
|
2018
Q4 | $10.8M | Buy |
|